Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LAMC1 antisense RNA 1 (LAMC1-AS1) is a long non-coding antisense transcript overlapping the LAMC1 genomic locus. While antisense lncRNAs can modulate the expression of nearby or related genes via RNA-RNA interactions, chromatin interactions, or recruitment of protein complexes, there is no direct experimental literature describing the function, disease relevance, or therapeutic potential of LAMC1-AS1 itself[1][4][6]. The naming is distinct from TM4SF19-AS1 or other antisense lncRNAs implicated in cancer, and LAMC1-AS1 should not be conflated with the functional extracellular matrix protein LAMC1, which is involved in cell migration, invasion, and cancer biology[2][3][5]. Information on the precise sequence, tissue expression, or phenotype for LAMC1-AS1 is lacking in published research and curated databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LAMC1 antisense RNA 1 (LAMC1-AS1).